⚗️ Todos los productos son exclusivamente para investigación científica — no para consumo humano.
PeptideLATAM
Inicio / Guías de Investigación / Longevity and Anti-aging Research
Guía de Investigación · Actualizada Marzo 2026

Longevity and Anti-aging Research

Telomere biology, epigenetic regulation, and extracellular matrix remodelling

Solo para investigación: Toda la información es exclusivamente para fines de investigación científica. Estos péptidos no están no aprobados para uso terapéutico humano. Cumpla con los requisitos éticos y regulatorios de su institución.

¿Qué es esta Categoría?

Epithalon and GHK-Cu sit at the frontier of longevity science. Epithalon is a synthetic tetrapeptide developed by Russian gerontologist Vladimir Khavinson from pineal gland extracts. It is one of the very few compounds shown in peer-reviewed studies to activate telomerase — the enzyme responsible for repairing the ends of chromosomes — in human cell cultures. Longer telomeres are associated with slower cellular ageing and reduced age-related disease risk. GHK-Cu is a naturally occurring copper-peptide complex found in human plasma, saliva, and urine. Its concentration drops dramatically with age — from ~200 ng/mL at age 20 to under 80 ng/mL by age 60 — and it regulates an extraordinary number of biological processes including collagen production, antioxidant defence, anti-inflammatory signalling, and stem cell activation. Both peptides attract significant interest from the longevity research and biohacker communities.

Para Qué se Investiga

  • Telomere length maintenance and cellular longevity research (Epithalon)
  • Improving skin quality, thickness, and collagen density (GHK-Cu, especially topical)
  • Circadian rhythm normalisation and sleep quality improvement (Epithalon)
  • General anti-ageing protocol — often cycled twice yearly (Epithalon)
  • Wound healing acceleration and scar reduction (GHK-Cu)
  • Studying epigenetic age reversal mechanisms

Pros y Contras

+Epithalon: in vitro human cell evidence for telomerase activation — rare and significant for a research peptide
+GHK-Cu regulates 4,000+ human genes according to transcriptomic analysis — unusually broad biological activity
+GHK-Cu available in both injectable and topical forms — accessible entry point without injections
+Decades of research behind both compounds (Khavinson's Epithalon work since the 1980s)
+No significant toxicity in rodent studies at high doses
+Epithalon may normalise melatonin secretion — secondary sleep and circadian benefit
Epithalon's telomerase activation is demonstrated in vitro (cell cultures); robust in vivo human evidence is limited
Theoretical concern: activating telomerase in cells with pre-existing DNA damage could theoretically promote cancer cell survival
GHK-Cu topicals have significantly lower penetration than injectable — skin benefits differ in magnitude
Epithalon courses are short (10–20 injections) but need to be repeated; total cost accumulates
Long-term human safety data for Epithalon is absent in Western regulatory review contexts
Longevity effects are inherently difficult to measure in the short term

Cronología de Efectos

Basado en cronogramas de estudios publicados. La extrapolación humana es aproximada — los resultados individuales varían.

Inicio
Days 3–14 (GHK-Cu skin/wound); Weeks 1–3 (Epithalon systemic)
Efecto Máximo
End of course for Epithalon; ongoing with GHK-Cu
Notas

GHK-Cu wound healing effects are measurable within 14 days in animal models. Epithalon's telomere effects are assessed at the end of a 10–20 day course in published studies. Circadian and sleep quality improvements from Epithalon are often reported within the first 5–7 days of a course by self-researchers.

Estatus Legal en LATAM: Epithalon and GHK-Cu are unscheduled research chemicals in Latin America with no controlled substance status. Neither is approved as a medicine by COFEPRIS or regional authorities. GHK-Cu is widely used in cosmetics (legal topical use). Injectable forms are sold as research compounds. Purchase legality varies by country — verify local regulations.

Resumen Científico

Epithalon (Epitalon) and GHK-Cu are among the most studied peptides in longevity research. Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed from the pineal gland extract Epithalamin, demonstrated to activate telomerase (TERT) and extend mean telomere length in cultured human cells. GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex that regulates gene expression across >4,000 genes, with particularly strong effects on extracellular matrix (ECM) remodelling, antioxidant defence, and anti-inflammatory signalling.

Mecanismo de Acción

Epithalon upregulates telomerase reverse transcriptase (TERT) expression, enabling telomere elongation in somatic cells that would otherwise undergo replicative senescence. It also normalises circadian melatonin secretion through pineal gland modulation. GHK-Cu activates the proteasome system, upregulates matrix metalloproteinases (MMP-1, MMP-2) for ECM remodelling, stimulates collagen I/III synthesis, and reduces oxidative stress via SOD1 upregulation.

Métodos de Administración

Vía 1Subcutaneous injection (Epithalon)
Preparación

Reconstitute in sterile saline to 1 mg/mL. Store at 4 °C, protect from light. Stable for 14 days after reconstitution.

Concentración Típica

0.5–1 mg/mL

Notas

SC is the standard route in published Khavinson studies. Typical courses are 10–20 injections administered in daily or every-other-day protocols.

Vía 2Subcutaneous / IV injection (GHK-Cu, systemic studies)
Preparación

Reconstitute lyophilised GHK-Cu in sterile saline. For IV administration, filter through 0.22 µm syringe filter.

Concentración Típica

1–5 mg/mL

Notas

IV administration is used in acute wound healing studies. SC and topical formulations are used for dermal ECM studies.

Vía 3Topical / transdermal (GHK-Cu)
Preparación

Dissolve in hydroxypropyl cellulose gel or PBS for ex vivo skin models. Concentration 0.05–2% w/v.

Concentración Típica

0.1–1% w/v

Notas

Topical GHK-Cu penetrates the stratum corneum and reaches the dermis. Used in wound healing assays and in vitro fibroblast studies.

Protocolos de Investigación

Telomere Length Study (Epithalon)
Epithalon
Duración
20-day course (repeated twice at 6-month intervals)
Frecuencia
Once daily SC injection
Rango de Dosificación
0.1–1 mg per animal (mouse); 0.01 mg/kg (rat)
Criterios de Evaluación

Telomere length (qPCR-based T/S ratio), TERT mRNA expression (RT-PCR), telomerase activity (TRAP assay), serum melatonin (ELISA)

Notas del protocolo: Originally validated in Khavinson et al. studies. Aged animals (18–24 months) show the most pronounced telomere effects.
Wound Healing Assay (GHK-Cu)
GHK-Cu
Duración
14 days
Frecuencia
Once daily topical or SC
Rango de Dosificación
Topical: 2% gel twice daily; SC: 1 mg/kg once daily
Criterios de Evaluación

Wound closure rate (planimetry, %) at days 3, 7, 14; collagen content (hydroxyproline assay); MMP-1 activity (zymography)

Notas del protocolo: Full-thickness excisional wound model. GHK-Cu group consistently shows 20–40% faster closure than vehicle in published data.
Circadian Rhythm Normalisation (Epithalon)
Epithalon
Duración
30 days
Frecuencia
Once daily, administered at the same time of day (ZT12)
Rango de Dosificación
0.1 mg/kg
Criterios de Evaluación

Pineal melatonin secretion (24-hour plasma sampling), locomotor activity rhythms (wheel running), Per1/Per2 clock gene expression

Notas del protocolo: Aged rodents show disrupted circadian melatonin rhythms. Epithalon has demonstrated normalising effects in several Khavinson group studies.

Estudios Publicados Clave

Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells

2003

Epithalon activated telomerase in human fibroblast and retinal epithelial cultures, increasing relative telomere length and extending the replicative lifespan of treated cells by 3–4 passages.

Metodología: In vitro human cell lines (WI-38, MRCS), TRAP assay, Southern blot telomere analysis
PubMed: 12792483

GHK-Cu: a peptide that initiates and manages many biological processes to reduce the consequences of aging

2012

GHK-Cu regulates more than 4,000 human genes, with notable upregulation of antioxidant genes (SOD1, catalase) and collagen synthesis, and downregulation of inflammation-associated genes (IL-1β, NF-κB).

Metodología: Transcriptomic meta-analysis of published microarray datasets; validation in dermal fibroblast culture
PubMed: 22725668

Resultados Esperados

Basado en la evidencia preclínica publicada. Los resultados pueden variar según el modelo, la dosis y la vía de administración.

  • Increased telomere length (T/S ratio) in aged rodent tissues after Epithalon course
  • Upregulation of TERT expression in proliferating cells
  • Normalised melatonin secretion profile in aged animals
  • Accelerated wound closure (20–40% faster vs. vehicle) with GHK-Cu
  • Increased collagen I and III synthesis in dermal fibroblasts (hydroxyproline, qPCR)
  • Reduced oxidative stress markers (MDA, 8-OHdG) in treated tissues

Consideraciones de Seguridad

  • Epithalon has not shown toxicity in rodent studies up to 10 mg/kg.
  • GHK-Cu copper content is low (tripeptide stoichiometry); no evidence of copper toxicity at research doses.
  • Telomerase activation carries theoretical oncogenic risk in rapidly dividing cells; all studies should include appropriate duration and monitoring controls.
  • Not approved for human therapeutic use.

Preguntas Frecuentes

What makes Epithalon distinct from other telomere-targeting compounds?

Unlike direct telomerase activators (e.g., TA-65), Epithalon appears to act via epigenetic regulation of TERT gene expression rather than direct enzyme activation. This results in a more sustained upregulation of endogenous telomerase rather than acute enzyme activation.

Can GHK-Cu penetrate the skin for topical studies?

Yes. GHK-Cu has a molecular weight of ~340 Da (well below the 500 Da cutoff for transdermal penetration) and a lipophilic character that facilitates stratum corneum passage. Ex vivo skin penetration studies confirm dermis-level concentrations within 4–8 hours of topical application.

Notas Prácticas para Auto-Investigadores

Solo con fines educativos. La autoadministración de compuestos de investigación conlleva riesgos significativos y no respaldado por PeptideLATAM. Consulte a un profesional de salud calificado antes de considerar cualquier protocolo de autoinvestigación.

How long is an Epithalon course and how often should it be repeated?

Published Khavinson studies use 10–20 daily subcutaneous injections as a single course. Self-researchers commonly repeat this once or twice per year. There is no established optimal frequency for humans — annual or biannual cycling is based on the schedule used in animal longevity studies, not human-specific data.

Which is better for skin: topical or injectable GHK-Cu?

For dermal effects specifically (collagen, wound healing, skin thickness), topical GHK-Cu reaches dermis-level concentrations within hours and is the most practical approach. Injectable GHK-Cu provides systemic distribution that topical cannot achieve. Many self-researchers use both: topical for skin and injectable for systemic effects. Topical products are widely available commercially without requiring peptide sourcing.

Is it safe to take Epithalon if I have a personal or family history of cancer?

This is an important consideration. Telomerase is overexpressed in approximately 90% of human cancers, as it enables cancer cells to replicate indefinitely. Activating telomerase in an individual with pre-existing cellular abnormalities carries theoretical risk. Most published Epithalon studies have not tracked oncological outcomes over long timeframes. This is a question to discuss with a healthcare professional — not a determination we can make from preclinical data alone.

Obtén Péptidos para tu Investigación

Compara proveedores de péptidos accesibles para LATAM en pureza, análisis, disponibilidad de envío verificada y precio por mg.